Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
minocycline (minocin) (1 trial)
nicotine (nicorette) (1 trial)
ubiquinone (1 trial)
Atrophy (Phase 3)
Multiple System Atrophy (Phase 3)
Paralysis (Phase 2)
Parkinson Disease (Phase 2)
Shy-Drager Syndrome (Phase 3)
Supranuclear Palsy, Progressive (Phase 2)
Trials (3 total)
Trial APIs (3 total)